Evidence map›Paper›PMID 31969629›Full record

ArticleScientific reports2020

Elevated circulating CD14

Jana C Mossanen, Tobias U Jansen, Jessica Pracht, Anke Liepelt, Lukas Buendgens, Christian Stoppe, Andreas Goetzenich, Tim-Philipp Simon, Rüdiger Autschbach, Gernot Marx and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Leukocyte dynamics inFrontiers in immunology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jana C Mossanen *Department of Medicine III, University Hospital Aachen, Aachen, Germany. jana.mossanen@gmail.com.
Tobias U Jansen *Department of Medicine III, University Hospital Aachen, Aachen, Germany.
Jessica PrachtDepartment of Medicine III, University Hospital Aachen, Aachen, Germany.
Anke LiepeltDepartment of Medicine III, University Hospital Aachen, Aachen, Germany.
Lukas BuendgensDepartment of Medicine III, University Hospital Aachen, Aachen, Germany.
Christian StoppeDepartment of Intensive and Intermediate Care, University Hospital Aachen, Aachen, Germany.
Andreas GoetzenichDepartment of Thoracic and Cardiovascular Surgery, University Hospital Aachen, Aachen, Germany.
Tim-Philipp SimonDepartment of Intensive and Intermediate Care, University Hospital Aachen, Aachen, Germany.
Rüdiger AutschbachDepartment of Thoracic and Cardiovascular Surgery, University Hospital Aachen, Aachen, Germany.
Gernot MarxDepartment of Intensive and Intermediate Care, University Hospital Aachen, Aachen, Germany.
Frank TackeDepartment of Medicine III, University Hospital Aachen, Aachen, Germany.
Universitätsklinikum Aachen · DECharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elective cardiac surgery has low procedural complications. However, about 40% of patients develop extracardiac complications including delirium and acute kidney injury. We hypothesized that inflammatory processes and immune cell activation might be associated with these complications. We therefore prospectively included 104 patients undergoing cardiac surgery in our study. We assessed peripheral blood leukocyte populations by flow cytometry and circulating cytokines before operation, after surgery and at days one and four post-operatively. Patients undergoing cardiac surgery showed significantly elevated leukocytes and neutrophils after surgery. On the contrary, monocytes decreased after surgery and significantly increased at days 1 and 4, particularly classical (Mon1,CD14++CD16-) and intermediate (Mon2,CD14++CD16+) monocytes. While peripheral leukocyte subsets were unaltered in patients with infectious (n = 15) or cardiac complications (n = 31), post-operative leukocytes (p = 0.0016), neutrophils (p = 0.0061) and Mon2 (p = 0.0007) were clearly raised in patients developing extracardiac complications (n = 35). Using multiple logistic regression analyses, patient's age, ICU days, number of blood transfusions and elevated post-surgery Mon2 independently predicted extracardiac complications. Our findings demonstrate that elevated Mon2 after cardiac surgery are associated with an increased risk for extracardiac complications. These findings might improve the risk estimation after cardiac operations and the role of Mon2 for inflammation in cardiac surgery.

Indexed as

Leukocyte CountLipopolysaccharide ReceptorsMonocytesReceptors, IgGAcute Kidney InjuryAdultAgedAged, 80 and overBiomarkersCardiac Surgical ProceduresDeliriumFemaleFlow CytometryHumansMaleMiddle AgedBiomarkersLipopolysaccharide ReceptorsReceptors, IgG

Identifiers

PMID31969629
PMCPMC6976615
OpenAlexW3002693767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.